Entero Therapeutics Inc (NASDAQ:ENTO) has a beta value of -99.96% and has seen 1.53 shares traded in the last trading session. The company, currently valued
During the last session, Entero Therapeutics Inc (NASDAQ:ENTO)’s traded shares were 0.14 million, with the beta value of the company hitting 0.84. At the end
In the last trading session, 0.1 million shares of the Entero Therapeutics Inc (NASDAQ:ENTO) were traded, and its beta was 0.81. Most recently the company’s
In last trading session, Entero Therapeutics Inc (NASDAQ:ENTO) saw 0.72 million shares changing hands with its beta currently measuring 0.85. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne